Showing results (3021-3030 of 27,713) with videos related to
Sort By:
Pageof 2,772
Vaccine|October 5, 2007
Anthrax vaccination in a military population before the war in Iraq: side effects and informed choiceDominic Murphy, Lisa Hull, Oded Horn, et al.Vaccine|December 1, 2006
Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of lifeN Guiso, E Njamkepo, F Vié le Sage, et al.Vaccine|August 2, 2006
Heterogeneity of influenza case definitions and implications for interpreting and comparing study resultsKristin L NicholVaccine|March 1, 1990
Protective potential of hepatitis B virus antigens other than the S gene proteinW H Gerlich, R Deepen, K H Heermann, et al.Vaccine|September 5, 2006
Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine developmentDon Yuen, Wai-Hang Leung, Randy Cheung, et al.Vaccine|September 5, 2006
Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse modelA Tammiruusu, T Penttilä, R Lahesmaa, et al.Vaccine|September 26, 2006
Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infectionAdam Linder, Susan Hollingshead, Robert Janulczyk, et al.Vaccine|October 13, 2006
Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in childrenIsabelle Henckaerts, Nathalie Durant, Dany De Grave, et al.Vaccine|October 13, 2006
Animal models for protein pneumococcal vaccine evaluation: a summaryM C Steinhoff, Vaccine|October 19, 2006
Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175Priyabrata Pattnaik, Ahmad Rushdi Shakri, Shailja Singh, et al.Pageof 2,772